학술논문
COVID-19 Myopericarditis in a Young Healthy Male.
Document Type
Academic Journal
Author
Bandeira M; Serviço de Reumatologia, Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.; Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.; Serrazina J; Serviço de Gastrenterologia e Hepatologia, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Santos CA; Serviço de Medicina II, Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Jacinto N; Serviço de Medicina II, Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Critical Care Department, Hospital Professor Doutor Fernando da Fonseca, Amadora, Portugal.; Pais de Lacerda A; Serviço de Medicina II, Clínica Universitária Medicina II, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
Source
Publisher: SMC Media Country of Publication: Italy NLM ID: 101648453 Publication Model: eCollection Cited Medium: Internet ISSN: 2284-2594 (Electronic) Linking ISSN: 22842594 NLM ISO Abbreviation: Eur J Case Rep Intern Med Subsets: PubMed not MEDLINE
Subject
Language
English
Abstract
SARS-CoV-2 infection can present in different clinical forms, most commonly as bilateral pneumonia, but also with pericardial/myocardial involvement. Cardiac involvement in COVID-19 is associated with worse outcomes. The authors report a case of myopericarditis as the primary manifestation of SARS-CoV-2 infection in a 20-year-old male patient with no known cardiovascular (CV) disorders or risk factors. The patient presented with pleuritic chest pain and high fever, with no respiratory symptoms. Electrocardiogram (ECG) and echocardiogram changes were consistent with pericarditis; concomitant elevation of cardiac enzymes revealed myocardial involvement. The patient had a slow but favourable evolution with no apparent impact on cardiac function. Other causes of myopericarditis were excluded and SARS-CoV-2 admitted as the most likely aetiological agent. This case highlights possible cardiac involvement in SARS-CoV-2 infection with little or no pulmonary disease in a young healthy patient. Such systemic and potentially troublesome manifestations of COVID-19 are increasingly being described.
Learning Points: Acute myopericarditis is a possible manifestation of SARS-CoV-2 infection.SARS-CoV-2 cardiac involvement may occur both in older and in younger previously healthy subjects, and could be more frequent than expected.Further investigation should address the prevalence of myocardium and pericardium involvement in COVID-19 patients, as well as its complications, sequelae and prognostic value for both older and young patients.
Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interest
(© EFIM 2022.)
Learning Points: Acute myopericarditis is a possible manifestation of SARS-CoV-2 infection.SARS-CoV-2 cardiac involvement may occur both in older and in younger previously healthy subjects, and could be more frequent than expected.Further investigation should address the prevalence of myocardium and pericardium involvement in COVID-19 patients, as well as its complications, sequelae and prognostic value for both older and young patients.
Competing Interests: Conflicts of Interests: The Authors declare that there are no competing interest
(© EFIM 2022.)